Cargando…
Cardiovascular Damage in COVID-19: What We Know Two Years Later
PURPOSE OF THE REVIEW: The Coronavirus disease 2019 (COVID-19) pandemic has profoundly influenced cardiological clinical and basic research in the past two years. In the present review, we summarize the current knowledge on myocardial involvement in COVID-19, providing an overview on the incidence,...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244358/ https://www.ncbi.nlm.nih.gov/pubmed/35751835 http://dx.doi.org/10.1007/s11886-022-01730-4 |
_version_ | 1784738507011391488 |
---|---|
author | Nuzzi, Vincenzo Del Mestre, Eva Degrassi, Alessia Bromage, Daniel I. Manca, Paolo Piper, Susan Artico, Jessica Gentile, Piero Scott, Paul A. Chiatto, Mario Merlo, Marco Pareek, Nilesh Giacca, Mauro Sinagra, Gianfranco McDonagh, Theresa A. Cannata, Antonio |
author_facet | Nuzzi, Vincenzo Del Mestre, Eva Degrassi, Alessia Bromage, Daniel I. Manca, Paolo Piper, Susan Artico, Jessica Gentile, Piero Scott, Paul A. Chiatto, Mario Merlo, Marco Pareek, Nilesh Giacca, Mauro Sinagra, Gianfranco McDonagh, Theresa A. Cannata, Antonio |
author_sort | Nuzzi, Vincenzo |
collection | PubMed |
description | PURPOSE OF THE REVIEW: The Coronavirus disease 2019 (COVID-19) pandemic has profoundly influenced cardiological clinical and basic research in the past two years. In the present review, we summarize the current knowledge on myocardial involvement in COVID-19, providing an overview on the incidence, the pathogenetic mechanisms, and the clinical implications of cardiac injury in this setting. RECENT FINDINGS: The possibility of heart involvement in patients with COVID-19 has received great attention since the beginning of the pandemic. After more than two years, several steps have been taken in understanding the mechanisms and the incidence of cardiac injury during COVID-19 infection. Similarly, studies globally have clarified the implications of co-existing heart disease and COVID-19. SUMMARY: Severe COVID-19 infection may be complicated by myocardial injury. To date, a direct damage from the virus has not been demonstrated. The presence of myocardial injury should be systematically assessed for a prognostication purpose and for possible therapeutic implications. |
format | Online Article Text |
id | pubmed-9244358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-92443582022-06-30 Cardiovascular Damage in COVID-19: What We Know Two Years Later Nuzzi, Vincenzo Del Mestre, Eva Degrassi, Alessia Bromage, Daniel I. Manca, Paolo Piper, Susan Artico, Jessica Gentile, Piero Scott, Paul A. Chiatto, Mario Merlo, Marco Pareek, Nilesh Giacca, Mauro Sinagra, Gianfranco McDonagh, Theresa A. Cannata, Antonio Curr Cardiol Rep Myocardial Disease (A Abbate and M Merlo, Section Editors) PURPOSE OF THE REVIEW: The Coronavirus disease 2019 (COVID-19) pandemic has profoundly influenced cardiological clinical and basic research in the past two years. In the present review, we summarize the current knowledge on myocardial involvement in COVID-19, providing an overview on the incidence, the pathogenetic mechanisms, and the clinical implications of cardiac injury in this setting. RECENT FINDINGS: The possibility of heart involvement in patients with COVID-19 has received great attention since the beginning of the pandemic. After more than two years, several steps have been taken in understanding the mechanisms and the incidence of cardiac injury during COVID-19 infection. Similarly, studies globally have clarified the implications of co-existing heart disease and COVID-19. SUMMARY: Severe COVID-19 infection may be complicated by myocardial injury. To date, a direct damage from the virus has not been demonstrated. The presence of myocardial injury should be systematically assessed for a prognostication purpose and for possible therapeutic implications. Springer US 2022-06-25 2022 /pmc/articles/PMC9244358/ /pubmed/35751835 http://dx.doi.org/10.1007/s11886-022-01730-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Myocardial Disease (A Abbate and M Merlo, Section Editors) Nuzzi, Vincenzo Del Mestre, Eva Degrassi, Alessia Bromage, Daniel I. Manca, Paolo Piper, Susan Artico, Jessica Gentile, Piero Scott, Paul A. Chiatto, Mario Merlo, Marco Pareek, Nilesh Giacca, Mauro Sinagra, Gianfranco McDonagh, Theresa A. Cannata, Antonio Cardiovascular Damage in COVID-19: What We Know Two Years Later |
title | Cardiovascular Damage in COVID-19: What We Know Two Years Later |
title_full | Cardiovascular Damage in COVID-19: What We Know Two Years Later |
title_fullStr | Cardiovascular Damage in COVID-19: What We Know Two Years Later |
title_full_unstemmed | Cardiovascular Damage in COVID-19: What We Know Two Years Later |
title_short | Cardiovascular Damage in COVID-19: What We Know Two Years Later |
title_sort | cardiovascular damage in covid-19: what we know two years later |
topic | Myocardial Disease (A Abbate and M Merlo, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244358/ https://www.ncbi.nlm.nih.gov/pubmed/35751835 http://dx.doi.org/10.1007/s11886-022-01730-4 |
work_keys_str_mv | AT nuzzivincenzo cardiovasculardamageincovid19whatweknowtwoyearslater AT delmestreeva cardiovasculardamageincovid19whatweknowtwoyearslater AT degrassialessia cardiovasculardamageincovid19whatweknowtwoyearslater AT bromagedanieli cardiovasculardamageincovid19whatweknowtwoyearslater AT mancapaolo cardiovasculardamageincovid19whatweknowtwoyearslater AT pipersusan cardiovasculardamageincovid19whatweknowtwoyearslater AT articojessica cardiovasculardamageincovid19whatweknowtwoyearslater AT gentilepiero cardiovasculardamageincovid19whatweknowtwoyearslater AT scottpaula cardiovasculardamageincovid19whatweknowtwoyearslater AT chiattomario cardiovasculardamageincovid19whatweknowtwoyearslater AT merlomarco cardiovasculardamageincovid19whatweknowtwoyearslater AT pareeknilesh cardiovasculardamageincovid19whatweknowtwoyearslater AT giaccamauro cardiovasculardamageincovid19whatweknowtwoyearslater AT sinagragianfranco cardiovasculardamageincovid19whatweknowtwoyearslater AT mcdonaghtheresaa cardiovasculardamageincovid19whatweknowtwoyearslater AT cannataantonio cardiovasculardamageincovid19whatweknowtwoyearslater |